Furthermore, researchers have found that the elevation of local CHI3L1 increases the ability of metastatic tumors to colonize and proliferate, and there is a significant increase in CHI3L1 levels in serum for patients with metastatic breast cancer, indicating the association between CHI3L1 and worse clinical outcomes [15,16]. This evidence concerns the gene CHI3L1 and metastatic neoplasm.